Table 5 Clinical outcomes analysis of group 2
No declared delayed access n = 87 (84.5%) | Declared delayed access n = 16 (15.5%) | p-value | Crude OR (95% CI), p-value | Adjusted OR* (95% CI), p-value | |
|---|---|---|---|---|---|
Intra-operative complications, n (%) | 0 (0.0) | 1 (8.3) | 0.13 | ||
Morbidity, n (%) | 15 (18.3) | 5 (41.7) | OR = 3.19 (0.89–11.44) p = 0.07 | aOR = 2.31 (0.51–10.45) p = 0.28 | |
Dindo-Clavien 0–2, n (%) | 73 (89.0) | 10 (83.3) | 0.01 | n.a. | n.a. |
Dindo-Clavien 3–4, n (%) | 9 (11.0) | 0 (0.0) | |||
Dindo-Clavien 5, n (%) | 0 (0.0) | 2 (16.7) | |||
Blood transfusions, n (%) | 5 (6.10) | 3 (25.0) | OR = 5.13 (1.05–25.15) p = 0.04 | aOR = 3.70 (0.63–21.60) p = 0.15 | |
30-day mortality, n (%) | 2 (2.4) | 2 (16.7) | OR = 8.00 (1.01–63.23) p = 0.05 | aOR = 3.65 (0.24–54.69) p = 0.35 | |
Stoma** | 3 (6.5) | 1 (10.0) | 1.59 (0.15–17.1) p = 0.70 | aOR = 1.11 (0.07–18.52) p = 0.94 |